Healthcare
Sofinnova Partners lists DBV
Paris-based Sofinnova Partners has listed DBV Technologies, raising €40.5m in the IPO on NYSE Euronext Paris.
Sambrinvest joins €23.6m series-B round in bioscience
Sambrinvest has joined Mitsui Global Investment, Shire, ATMI and the Boehringer Ingelheim Venture Fund to invest €17m in Belgian cell therapy company Promethera Biosciences. The Walloon region has granted a further €6.6m in the form of a loan.
Ashridge back special needs care provider Phoenix
Ashridge Capital has invested £3.5m in a management buyout of special needs care provider Phoenix Learning and Care.
Imperial Innovations leads £3m funding round in Abingdon Health
Imperial Innovations Group has led a £3m funding round in Abingdon Health, a specialist medical diagnostics company, alongside other private investors.
Seventure and Lundbeckfond inject €5m in Enterome
Seventure Partners and Lundbeckfond Ventures have provided French biotech company Enterome with a €5m series-A round of funding.
HTGF invests in hepatitis drug project
High-Tech Gründerfonds and Russian Government-backed Maxwell Biotech Venture Fund have invested in a joint project to develop a drug aimed at the treatment of chronic hepatitis B and D.
venBio leads CHF 37m funding round for Cytos
An international syndicate of investors comprised of venBio, Amgen, Aisling Capital and Abingworth has invested up to CHF 37m in equity and debt in Swiss biotech company Cytos Biotechnology Ltd.
Index Ventures closes life sciences fund at €150m
Index Ventures has closed its latest life sciences fund, raising €150m from LPs and pharmaceutical companies.
MMC Ventures announces second venture capital fund
MMC Ventures launches its second venture capital fund for young investors. The MMC Growth Generation Fund is available to investors aged 18-35 with £2,500 to £10,000 to invest.
Duke Street considers Biomnis exit
Mid-market GP Duke Street has appointed Crédit Suisse to review options - including a potential sale - for French medical analysis business Biomnis, according to a spokesperson.
Invercaria and la Caixa back nLife
Invercaria and la Caixa have invested €5m in Granada-based nanomedicine company nLife Therapeutics in exchange for a minority stake.
Montezemolo acquires Bellco
Montezemolo & Partners SGR has acquired biomedical company Bellco from Argos Soditic and MPVenture.
Apposite reaps 45% IRR on SureCalm exit
Specialist healthcare investor Apposite Capital has sold homecare services provider SureCalm Healthcare to medical technologies developer Amcare Ltd, reaping a 45% IRR.
YFM and EV reinvest in Peckforton Pharmaceuticals
YFM Equity Partners and Enterprise Ventures have joined the management in investing over £1m in portfolio company Peckforton Pharmaceuticals.
Synova Capital acquires TAG Medical
Synova Capital's portfolio company dbg, service and product provider to the dental sector, has acquired medical equipment firm TAG Medical.
Sovereign portfolio company acquires Sage Care
Sovereign Capital portfolio company City & County Healthcare Group has completed the bolt-on acquisition of care provider for the elderly Sage Care in a transaction funded from the company’s existing balance sheet.
HTGF and Bayern Kapital back seiratherm
High-Tech Gründerfonds (HTGF), Bayern Kapital and a strategic partner have announced their intention to invest in medical equipment firm seiratherm.
PE-backed EOS Imaging in €120m IPO
French medical devices business EOS Imaging, a portfolio company of Edmond de Rothschild Investment Partners (EdRIP) and NBGI Ventures among other investors, has listed on NYSE Euronext.
MKB+ invests €3m in Aeon Astron Europe
Innovatiefonds MKB+ has made the first venture investment in Dutch biotech company Aeon Astron Europe.
August-backed Active Assistance acquires Neural Pathways
August Equity LLP portfolio company Active Assistance, a clinical care services provider, has acquired rehabilitation therapy provider Neural Pathways Limited from managing director Vikki Gilman.
Doughty Hanson acquires USP Hospitales for €355m
Doughty Hanson has acquired Spanish hospitals operator USP Hospitales from Barclays and Royal Bank of Scotland for €355m, 9x the firm's forecast EBITDA for 2012.
RJD reaps 1.5x on partial exit from Raphael Healthcare
RJD Partners has partially exited Raphael Healthcare in a refinancing, which has returned 1.5x of the original investment.
High-Tech Gründerfonds backs OakLabs
High-Tech Gründerfonds has invested in German biotech company Oaklabs.
Advent Life Sciences leads series-A for CN Creative
Advent Life Sciences has injected £2m of series-A funding into British healthcare equipment developer CN Creative.